The amino terminus of Cdk2 binds p21

Area of Science:

• Molecular Biology
• Cell Cycle Regulation
• Protein-Protein Interactions

Background:

• p21 is a cyclin-dependent kinase (Cdk) inhibitor that regulates cell cycle progression by inducing G1 arrest.
• Previous research indicated that amino acids 46-78 of p21 are essential for binding to Cdk2 and inhibiting its kinase activity.
• The specific binding sites on Cdk2 for p21 have not been identified.

Purpose of the Study:

• To identify the specific region(s) on Cdk2 responsible for binding to the cyclin-dependent kinase (Cdk) inhibitor p21.
• To investigate the role of different domains of Cdk2 in mediating p21 interaction.
• To complement existing crystallographic data on Cdk2-p21 interactions.

Main Methods:

• Construction and testing of various N-terminal and C-terminal deletion mutants of Cdk2 for p21 binding.
• Utilizing yeast two-hybrid and double-tagging assays to assess protein interactions.
• Creating and analyzing Cdk2/Cdk7 and Cdk2/Cdc28 hybrid proteins to map p21 binding domains.
• Mutagenesis of hybrid proteins to identify specific residues involved in p21 binding.

Main Results:

• Deletion mutants of Cdk2 did not bind to p21, suggesting the importance of intact domains.
• Hybrid molecules revealed that the amino-terminal half of Cdk2, but not Cdk7, is critical for p21 binding.
• The yeast protein Cdc28, homologous to Cdk2, also failed to bind p21, but Cdk2/Cdc28 hybrids could bind, further implicating Cdk2's N-terminus.
• Mutagenesis of hybrid proteins yielded mutants capable of binding p21, pinpointing key residues.

Conclusions:

• The amino-terminal half of Cdk2 is essential for binding to the Cdk inhibitor p21.
• Deletion of terminal regions may alter the three-dimensional structure of Cdk2, affecting p21 interaction.
• This study provides valuable insights into the molecular basis of Cdk2-p21 interaction and offers a method for identifying critical binding residues.